Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation Systems

 Lynn Kramer, MD, Appointed Chief Clinical Officer of Eisai Product Creation
                                   Systems

Newly Created Position to Strengthen Clinical Research

PR Newswire

WOODCLIFF LAKE, N.J., April 11, 2013

WOODCLIFF LAKE, N.J., April 11, 2013 /PRNewswire/ --Eisai Inc., the U.S.
pharmaceutical subsidiary of Eisai Co., Ltd., today announces the immediate
appointment of Lynn Kramer, MD, to the newly created position of chief
clinical officer of Eisai Product Creation Systems. In this role, Dr. Kramer
will be responsible for the approval of protocol designs of pivotal studies to
achieve timely regulatory approval of competitive labels for new products,
indications and life-cycle extensions. This includes the selection of study
regions and clinical sites. He also will provide oversight of the design of
Proof of Concept (POC) Studies for each of Eisai's Product Creation Units.

(Logo: http://photos.prnewswire.com/prnh/20120413/MM87168LOGO )

In addition to these new responsibilities, Dr. Kramer will continue to serve
as president of the Neuroscience and General Medicine Product Creation Unit, a
position he has held since July 2009. In this capacity, he is responsible for
overseeing the full product creation cycle from discovery through regulatory
approval of innovative projects in the neuroscience and general medicine
areas.

Dr. Kramer joined Eisai in 2007 as executive vice president of Global Clinical
Research and was soon promoted to the additional role of COO of Eisai Medical
Research. Upon the establishment of Eisai Product Creation Systems in 2009, he
accepted a dual appointment as president of the Neuroscience and General
Medicine Product Creation Unit and also the Scientific and Operational
Clinical Support (SOCS) Core Functional Unit. He held the SOCS position until
mid-2010.

Dr. Kramer is a Fellow of the American Board of Psychiatry and Neurology. He
currently serves as the industry representative on the Peripheral and Central
Nervous System Drugs Advisory Committee of the Food and Drug Administration
and is on the Board of Directors of the American Society for Experimental
NeuroTherapeutics (ASENT). Dr. Kramer also has been appointed to the newly
established Scientific Leadership Advisory Council of the Pharmaceutical
Research and Manufacturers of America (PhRMA). 

Dr. Kramer received his MD from Hahnemann Medical College. He completed his
internship in internal medicine at the University of California at Irvine and
his residency in neurology at the University of Virginia. Dr. Kramer also
holds a Bachelor of Arts from Lycoming College, where he has since been named
to the Board of Trustees.

Eisai Inc.
Eisai Inc. was established in 1995 and began marketing its first product in
the United States in 1997. Since that time, Eisai Inc. has rapidly grown to
become a fully integrated pharmaceutical business. Eisai's key areas of
commercial focus are neurology and oncology. The company serves as the U.S.
pharmaceutical operation of Eisai Co., Ltd., a research-based human health
care (hhc) company that discovers, develops and markets products throughout
the world.

Eisai has a global product creation organization that includes U.S.-based R&D
facilities in Massachusetts, New Jersey, North Carolina and Pennsylvania, as
well as manufacturing facilities in Maryland and North Carolina. The company's
areas of R&D focus include neuroscience; oncology; vascular, inflammatory and
immunological reaction; and antibody-based programs. For more information
about Eisai, please visit www.eisai.com/US.

Eisai Co., Ltd.
Eisai Co., Ltd. is a research-based human health care (hhc) company that
discovers, develops and markets products throughout the world. Through a
global network of research facilities, manufacturing sites and marketing
subsidiaries, Eisai actively participates in all aspects of the worldwide
healthcare system.

Media Inquiries
Suzanne Grogan
201-746-2083
suzanne_grogan@eisai.com

SOURCE Eisai Inc.

Website: http://www.eisai.com/US
 
Press spacebar to pause and continue. Press esc to stop.